This inventor holds 1 USPTO granted patent. Top assignees: Denka Company Limited, National Institute of Infectious Diseases, The Kitasato Institute. Active years: 2022.
Company Filing History:
1 out of 385 
1 out of 37 
1 out of 102 
Years Active: 2022
Title: Kengo Yoshikawa: Innovator in Norovirus Vaccine Development
Introduction
Kengo Yoshikawa is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of vaccine development, particularly focusing on norovirus. His innovative approach aims to enhance the effectiveness of vaccines through advanced molecular techniques.
Latest Patents
Yoshikawa holds a patent for a composite polypeptide monomer and its aggregate, which has a cell penetration function. This invention also includes a norovirus component vaccine designed for subcutaneous, intradermal, percutaneous, or intramuscular administration. The patent addresses the challenge of immunizing target cells effectively. The vaccine contains an associated product formed through the bonding of two molecules of a trimer of a molecular needle, which serves as the active ingredient.
Career Highlights
Throughout his career, Kengo Yoshikawa has worked with notable organizations, including Denka Company Limited and the Tokyo Institute of Technology. His experience in these institutions has allowed him to develop and refine his innovative ideas in vaccine technology.
Collaborations
Yoshikawa has collaborated with esteemed colleagues such as Takafumi Ueno and Megumi Mano. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
Kengo Yoshikawa's work in the field of vaccine development, particularly his innovative norovirus component vaccine, showcases his dedication to improving public health. His contributions are significant in the ongoing fight against viral infections.